Durham, NC, United States of America

Kaitlyn Andreano

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kaitlyn Andreano: Innovator in Breast Cancer Treatment

Introduction

Kaitlyn Andreano is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of cancer treatment, particularly focusing on breast cancer therapies. With a total of 6 patents to her name, her work is paving the way for innovative medical solutions.

Latest Patents

One of her latest patents involves the use of lasofoxifene for the treatment of estrogen receptor positive (ER) cancer in women. This patent outlines methods for administering an effective amount of lasofoxifene, a pharmaceutically acceptable salt, or a prodrug thereof. Additionally, it includes the detection of mutations in the Estrogen Receptor 1 (ESR1) gene that contribute to endocrine resistance in ER cancers. This groundbreaking work aims to improve treatment outcomes for patients facing endocrine-resistant cancers.

Career Highlights

Kaitlyn Andreano is affiliated with Duke University, where she conducts her research and develops her innovative treatments. Her dedication to advancing cancer therapies has positioned her as a key figure in the medical research community.

Collaborations

She collaborates with esteemed colleagues, including Ching-yi Chang and Donald P McDonnell, to further enhance her research efforts and contribute to the scientific community.

Conclusion

Kaitlyn Andreano's work in breast cancer treatment exemplifies the impact of innovation in medicine. Her patents and research are crucial in the fight against cancer, offering hope for improved therapies and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…